NCT00109941View on ClinicalTrials.gov

Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2009

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

opioid growth factor

OGF was administered in saline at 250 ug/kg intravenously over 45 minutes

BIOLOGICAL

metenkephalin, OGF-opioid growth factor

OGF given in saline iv 250 ug/kg weekly

Trial Locations (1)

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT00109941 - Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter